Moik, F.; van Es, N.; Posch, F.; Di Nisio, M.; Fuereder, T.; Preusser, M.; Pabinger, I.; Ay, C.
Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study. Cancers 2020, 12, 2493.
https://doi.org/10.3390/cancers12092493
AMA Style
Moik F, van Es N, Posch F, Di Nisio M, Fuereder T, Preusser M, Pabinger I, Ay C.
Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study. Cancers. 2020; 12(9):2493.
https://doi.org/10.3390/cancers12092493
Chicago/Turabian Style
Moik, Florian, Nick van Es, Florian Posch, Marcello Di Nisio, Thorsten Fuereder, Matthias Preusser, Ingrid Pabinger, and Cihan Ay.
2020. "Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study" Cancers 12, no. 9: 2493.
https://doi.org/10.3390/cancers12092493
APA Style
Moik, F., van Es, N., Posch, F., Di Nisio, M., Fuereder, T., Preusser, M., Pabinger, I., & Ay, C.
(2020). Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study. Cancers, 12(9), 2493.
https://doi.org/10.3390/cancers12092493